GoodRx Holdings, Inc.
GDRX
$3.44
-$0.01-0.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 785.23M | 787.89M | 796.85M | 800.65M | 799.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 785.23M | 787.89M | 796.85M | 800.65M | 799.87M |
| Cost of Revenue | 72.04M | 64.39M | 57.60M | 52.33M | 50.59M |
| Gross Profit | 713.19M | 723.50M | 739.26M | 748.33M | 749.28M |
| SG&A Expenses | 422.18M | 428.63M | 430.52M | 435.58M | 435.52M |
| Depreciation & Amortization | 88.64M | 86.10M | 85.22M | 81.17M | 77.27M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 695.99M | 695.47M | 690.66M | 692.90M | 686.33M |
| Operating Income | 89.24M | 92.42M | 106.20M | 107.76M | 113.54M |
| Income Before Tax | 41.40M | 45.51M | 56.54M | 53.75M | 55.77M |
| Income Tax Expenses | 25.15M | 24.95M | 26.10M | 22.00M | 21.17M |
| Earnings from Continuing Operations | 16.25 | 20.56 | 30.44 | 31.75 | 34.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.25M | 20.56M | 30.44M | 31.75M | 34.60M |
| EBIT | 89.24M | 92.42M | 106.20M | 107.76M | 113.54M |
| EBITDA | 177.88M | 178.51M | 191.41M | 173.16M | 175.05M |
| EPS Basic | 0.05 | 0.06 | 0.08 | 0.09 | 0.09 |
| Normalized Basic EPS | 0.10 | 0.11 | 0.13 | 0.13 | 0.14 |
| EPS Diluted | 0.04 | 0.06 | 0.08 | 0.09 | 0.09 |
| Normalized Diluted EPS | 0.10 | 0.11 | 0.13 | 0.13 | 0.14 |
| Average Basic Shares Outstanding | 1.37B | 1.38B | 1.42B | 1.46B | 1.50B |
| Average Diluted Shares Outstanding | 1.38B | 1.39B | 1.43B | 1.47B | 1.51B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |